Insights on Multiple Myeloma Treatment Strategies
María‐Victoria Mateos(Hospital Clínico San Carlos), Pieter Sonneveld(Erasmus MC Cancer Institute), Merav Leiba(Ben-Gurion University of the Negev), Michael O’Dwyer(Ollscoil na Gaillimhe – University of Galway), Mario Boccadoro(University of Turin), Jesús F. San Miguel(Clinica Universidad de Navarra), Thierry Façon(Université de Lille), Heinz Ludwig(Wilhelminen Hospital), Torben Plesner(University of Southern Denmark), Joan Bladé(Hospital Clínic de Barcelona), Niels W.C.J. van de Donk(Oncode Institute), Ali Bazarbachi(American University of Beirut), Meral Beksaç(Ankara University), Meletios Α. Dimopoulos(Korea University), Krzysztof Jamroziak(Instytut Hematologii i Transfuzjologi), Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Hartmut Goldschmidt(Heidelberg University), Christian Straka, Kwee Yong(CRUK Lung Cancer Centre of Excellence), Michèle Cavo(Unknown), Markus Hansson(Lund University), Samo Zver(Ljubljana University Medical Centre), Tamás Masszi, Roman Hájek(University Hospital Ostrava), Michel Delforge(KU Leuven), Philippe Moreau(Centre National de la Recherche Scientifique), Catarina Geraldes(Hospitais da Universidade de Coimbra)
Cited by 53
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Hematological findings and complications of <scp>COVID</scp>‐19
|American Journal of Hematology|2020|1.7k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k